Erratum to: Clin Drug Investig (2013) 33:761–771 DOI 10.1007/s40261-013-0126-5
Page 771, Reference 11, which previously read:
Bakish D, Gommoll C, Chen C, et al. Levomilnacipran ER 40 mg and 80 mg in major depressive disorder: a phase III, randomized, double-blind, fixed-dose, placebo-controlled study Int Clin Psychopharmacol. 2013 (in press).
Should read:
Bakish D, Bose A, Gommoll C, Chen C, Greenberg WM, et al. Levomilnacipran ER 40 mg and 80 mg in major depressive disorder: a phase III, randomized, double-blind, fixed-dose, placebo-controlled study. J Psychiatry Neurosci. 2013: doi: 10.11503/jpn.130040 (In Press)
Footnotes
The online version of the original article can be found under doi:10.1007/s40261-013-0126-5.